Immunotherapy in Gynecologic Cancers Shows Progress but Has a Long Way to Go
November 5th 2020
Ursula Matulonis, MD, highlights immunotherapy agents have demonstrated moderate clinical activity for patients with gynecologic cancers, however they fail to yield significant response rates in both the newly-diagnosed and recurrent settings.